S
Steven R. Feldman
Researcher at Wake Forest University
Publications - 1379
Citations - 43140
Steven R. Feldman is an academic researcher from Wake Forest University. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 83, co-authored 1227 publications receiving 37609 citations. Previous affiliations of Steven R. Feldman include Research Medical Center & Odense University Hospital.
Papers
More filters
Journal ArticleDOI
Current status and future prospects for biologic treatments of psoriasis.
TL;DR: As the psoriasis treatment armamentarium continues to expand, it is important to follow the safety profile of these drugs both in clinical trials and in post-marketing registries to ensure their long-term safety.
Journal ArticleDOI
Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary ☆
Steven R. Feldman,Susan D. Mathias,Brad Schenkel,Hilary H. Colwell,Kelly McQuarrie,Bruce Randazzo,Chenglong Han +6 more
TL;DR: The draft Psoriasis Symptoms and Signs Diary (PSSD), developed according to the Food and Drug Administration PRO Guidance, assesses severity of symptoms and signs commonly associated with plaque PsO.
Journal Article
Corrective cosmetics are effective for women with facial pigmentary disorders.
Rajesh Balkrishnan,Amy J. McMichael,Judy Y. Hu,Fabian Camacho,Mandeep Kaur,Anne Bouloc,Stephen R. Rapp,Steven R. Feldman +7 more
TL;DR: There was improvement in Skindex-16 scores after application of the corrective cosmetic, which continued at each follow-up visit and after adjustment for baseline confounders using multiple regression analyses.
Journal ArticleDOI
Increasing use of more potent treatments for psoriasis.
TL;DR: The most common medications used for psoriasis were topical steroids from 1986 to 2005 as mentioned in this paper, and the use of these potent drugs has increased from 1986-2005, with biologic therapies introduced in the 2001-to-2005 time period.
Journal ArticleDOI
Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data.
Mary-Margaret Bivens,Monali J. Bhosle,Rajesh Balkrishnan,Fabian Camacho,Steven R. Feldman,Alan B. Fleischer +5 more
TL;DR: Based on a representative sample of outpatient visit diagnoses, visits are not increasing for nonmelanoma skin cancer among patients 40 years and younger in the United States, albeit direct measurement of tumor incidence was not possible with this database.